HERSHEY TRUST COHERSHEY TRUST CO

Institutional investor · Portfolio as of Q2 2023

SEC EDGAR SourceSEC Filings

Top Holdings7 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
HSHSYFBDelisted

HERSHEY COMPANY CLASS B

54.6M$13.6B96.2%
18 qtrssince 2019-Q1
Decreased
0

HERSHEY CO/THE

2.1M$515.9M3.6%$231.250.00%
1 qtr
New
90

AIRBNB INC-CLASS A

100,093$12.8M0.1%$146.88-14.83%
8 qtrssince 2021-Q3
Increased
38
745,424$11.6M0.1%
Unchanged
0

CRISPR THERAPEUTICS AG

33,758$1.9M0.0%$121.82-53.19%
10 qtrssince 2021-Q1
Unchanged
0

ZOOMINFO TECHNOLOGIES INC

24,906$632,3630.0%$26.08-84.47%
1 qtr
New
37
RPTXRPTXDelisted

REPARE THERAPEUTICS INC

5,883$62,2420.0%$10.75
1 qtr
New
32
$14.2B
AUM
7
Positions
Q2 2023
Filing
Rating · 2.0
Quarterly Portfolio Change
-2%Q3'21$10.4B+14%Q4'21$11.9B+10%Q1'22$13.1B-3%Q2'22$12.7B+1%Q3'22$12.8B+5%Q4'22$13.5B
Activity profile
$ moved · Q2'23
New37%Increased0%Decreased63%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.6 years
<1Q14%1-4Q0%1-2Y14%2Y+71%

HERSHEY TRUST CO manages $14.2B across 7 positions as of Q2 2023. Top holdings: HSYFB (96.2%), HSY (3.6%), ABNB (0.1%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 2/5.0.

Q2 2023 Summary

Added 3 new positions, exited 2, increased 1, trimmed 1. Top move: HSY (NEW, conviction 90). Portfolio: $14.2B across 7 positions.

Top holdings by portfolio weight

Total AUM$14B
HSYFB96.17%
HSY3.64%
ABNB0.09%
MEITUAN DIAN0.08%
CRSP0.01%
GTM0.00%
RPTX0.00%
VYGR0.00%
PATH0.00%

Portfolio allocation by GICS sector

Sectors5
Unknown96.25%
Consumer Defensive3.64%
Consumer Cyclical0.09%
Healthcare0.01%
Technology0.00%

Behavioral investing profile

Checking access…
Momentum Trader- primarily Unknown
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track RecordNo data
Conviction39
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Top Losers

Checking access…

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used